Corneal infections caused by melanized molds represent a persistent and vision-threatening challenge in tropical and subtropical regions. Fungal corneal ulcers often trigger extensive tissue necrosis, leading to scarring, perforation, and irreversible visual impairment if appropriate therapy is delayed. Dematiaceous fungal keratitis has gained substantial clinical importance because these pigmented organisms display unique pathogenic traits and variable responses to standard ophthalmic antimycotics. A recent prospective study conducted at the Postgraduate Institute of Medical Education and Research in Chandigarh provides valuable real-world evidence regarding the burden, microbiological landscape, and therapeutic vulnerabilities of these challenging ocular infections.

Understanding Dematiaceous Fungal Keratitis Epidemiology

Dematiaceous fungi possess melanin within their cell walls, which confers structural rigidity and shields the pathogen against host immune defenses and environmental oxidative stress. In agricultural communities across India, vegetative ocular trauma frequently introduces these environmental saprophytes directly into the corneal stroma. Consequently, dematiaceous fungal keratitis accounts for a significant proportion of mycotic corneal ulcers in regional referral practices. The prospective investigation evaluated 1,931 individuals with suspected fungal keratitis between June 2023 and November 2025. Among these patients, laboratory testing confirmed fungal keratitis in 452 individuals. Dematiaceous molds caused 75 of these confirmed cases, representing an overall institutional prevalence of 3.88% among all suspected cases and nearly 17% among culture-confirmed mycotic ulcers. Therefore, clinicians must maintain a high index of suspicion whenever patients present with suppurative corneal lesions following agricultural or vegetative eye trauma.

Microbiological Spectrum and Molecular Identification

Accurate species identification remains vital because distinct dematiaceous molds exhibit divergent virulence and varying drug susceptibility patterns. In this prospective North Indian cohort, the researchers evaluated corneal specimens through direct microscopy using potassium hydroxide wet mounts and standard cultures on Sabouraud's dextrose agar. Furthermore, the investigative team utilized targeted DNA sequencing to achieve definitive species-level identification. The mycological analysis revealed marked genus diversity across the 75 isolates. Notably, Curvularia species emerged as the predominant etiological agent, accounting for 52% of all isolated dematiaceous strains. In addition, Alternaria species represented 12% of the cases, followed closely by Colletotrichum species at 10.66% and Exserohilum species at 8%. The researchers also identified eight other rare melanized genera. Consequently, this study demonstrates that while Curvularia remains the chief driver of dematiaceous corneal disease, rare opportunistic molds regularly contribute to severe ocular infections.

Clinical Features and Distinct Presentation

Recognizing the presenting signs of dematiaceous fungal keratitis enables clinicians to initiate targeted therapy promptly and prevent devastating complications. In this cohort, patients suffering from dematiaceous infections presented with acute inflammatory manifestations more frequently than patients with non-dematiaceous fungal ulcers. Specifically, ocular redness, excessive watering, and acute visual decline occurred at significantly higher rates. Although textbooks frequently highlight brownish or black stromal pigmentation as the classic hallmark of dematiaceous keratitis, clinicians often find that this pigment remains clinically subtle or entirely absent on slit-lamp biomicroscopy. Instead, lesions commonly present with dry, raised surfaces, feathery stromal infiltrates, and satellite lesions characteristic of filamentous fungi. Moreover, anterior chamber inflammation, including hypopyon formation, frequently accompanies moderate to severe infiltrates. Because clinical signs overlap significantly with bacterial and hyaline fungal ulcers, definitive microbiological diagnosis remains imperative before altering therapeutic regimens.

In Vitro Antifungal Susceptibility Testing Patterns

Antifungal susceptibility testing provides crucial guidance for selecting systemic and topical agents against refractory ocular mycoses. In this investigation, the researchers performed broth microdilution testing in accordance with Clinical Laboratory and Standards Institute guidelines across a comprehensive nine-drug panel. The evaluated agents included voriconazole, itraconazole, posaconazole, luliconazole, miconazole, ketoconazole, amphotericin B, natamycin, and terbinafine. Notably, voriconazole demonstrated consistently low minimum inhibitory concentrations ranging between 0.03 and 16 µg/ml against the isolated dematiaceous pathogens. Furthermore, newer and alternative antifungal options displayed potent in vitro efficacy. Specifically, luliconazole and terbinafine demonstrated remarkably low minimum inhibitory concentrations against the tested isolates. Conversely, natamycin, which serves as the traditional first-line topical suspension for filamentous keratitis, often demonstrated higher minimum inhibitory concentration values in vitro. These findings suggest that voriconazole and newer azoles possess favorable pharmacodynamic profiles against melanized corneal pathogens.

Therapeutic Implications and Clinical Decision-Making

The management of dematiaceous keratitis requires a coordinated medical and surgical strategy tailored to infiltrate depth, pathogen virulence, and treatment response. Although topical natamycin 5% suspension remains the conventional frontline therapy for superficial filamentous keratitis, its poor stromal penetration often limits its effectiveness against deep-seated infiltrates. In contrast, voriconazole 1% eye drops achieve superior intracorneal and anterior chamber concentrations. When clinical signs suggest progressive disease or deep stromal invasion, adding topical or oral voriconazole can significantly halt disease progression. Additionally, clinicians may consider targeted intrastromal voriconazole injections to deliver elevated local drug concentrations directly at the infiltrate margin. Meanwhile, the robust in vitro activity of luliconazole and terbinafine highlights exciting future opportunities for topical formulation development. Finally, timely surgical debridement reduces fungal burden and enhances drug bioavailability, whereas therapeutic keratoplasty remains necessary for impending or frank corneal perforation.

Frequently Asked Questions

What makes dematiaceous fungal keratitis clinically distinct from other fungal corneal infections?

Dematiaceous fungi possess melanin within their cell walls, which acts as a protective virulence factor against oxidative stress and host immune clearance. Although characteristic brownish corneal pigmentation may occasionally appear, many cases present with non-pigmented infiltrates that closely resemble hyaline fungal keratitis. Patients frequently report prominent conjunctival injection, marked watering, and acute vision loss, requiring systematic microbiological confirmation through smear and culture to differentiate them accurately.

Why does voriconazole show favorable activity against dematiaceous corneal isolates?

Voriconazole exhibits a broad spectrum of activity and superior tissue penetration across the corneal epithelium and deep stroma compared to polyene suspensions like natamycin. In vitro susceptibility testing from tertiary centers demonstrates that voriconazole achieves low minimum inhibitory concentration values against dematiaceous molds, particularly Curvularia species. Consequently, clinicians often employ topical or systemic voriconazole to treat refractory or deeply penetrating melanized fungal corneal infections.

Which fungal genera most frequently cause dematiaceous fungal keratitis in India?

In North India, Curvularia species serve as the predominant causative agent, responsible for more than half of all dematiaceous keratitis cases. Other prominent genera identified in clinical studies include Alternaria, Colletotrichum, and Exserohilum. Clinicians also occasionally isolate rarer genera such as Bipolaris, Cladosporium, and Phoma. Because clinical appearances remain similar across these genera, fungal culture and molecular sequencing are essential for precise identification.

Disclaimer: This content is for informational and educational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional for specific clinical decisions. Refer to the latest local and national guidelines for clinical practice.

References

Saroya A et al. Dematiaceous fungal keratitis: prevalence, spectrum, clinical features, outcome, and antifungal susceptibility from a tertiary care centre in North India. Med Mycol. 2026 Sep 18. doi: undefined. PMID: 42758129.

Tawde Y, Singh S, Das S, Rudramurthy SM, Kaur H, Gupta A. Clinical and mycological profile of fungal keratitis from North and North-East India. Indian J Ophthalmol. 2022;70(6):1972-1979.

Prajna NV, Krishnan T, Mascarenhas J, et al. The Mycotic Ulcer Treatment Trial: a randomized trial comparing natamycin vs voriconazole. JAMA Ophthalmol. 2013;131(4):422-429.